Stablepoint Partners, LLC Astrazeneca PLC Transaction History
Stablepoint Partners, LLC
- $552 Billion
- Q1 2025
A detailed history of Stablepoint Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Stablepoint Partners, LLC holds 21,825 shares of AZN stock, worth $1.6 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
21,825
Previous 20,993
3.96%
Holding current value
$1.6 Million
Previous $1.38 Billion
16.62%
% of portfolio
0.29%
Previous 0.25%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,371Shares Held
476MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.44 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.01 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.76 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.77 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.43 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...